An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 280 | |
Additional information about NCT01323192.
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 280 | |